A Multidisciplinary Discussion on Implementing Integrated Continuous Glucose Monitoring Into Practice

This activity includes patient counseling video vignettes and an iCGM device demonstration.  

Program Description

The role of continuous glucose monitoring (CGM) devices is evolving and advancing the landscape of diabetes management. The American Diabetes Association has incorporated CGM devices into diabetes treatment guidelines, and pharmacists and pharmacy technicians have important roles in identifying patients with diabetes who would benefit from use of integrated CGM (iGCM) to improve diabetes care. Pharmacists and pharmacy technicians can maximize the benefits of iCGM devices for patients with diabetes through appropriate patient education, device training, and overcoming access barriers. In this multidisciplinary panel discussion, experts will highlight the impact of iCGM technology in the management of patients with diabetes and share real-world experience and best practices with implementing iCGM in practice. Additionally, this panel will feature counseling and device demonstration videos to emphasize important discussion points for implementing iCGM in patients with diabetes.

Target audience: Retail pharmacists, health-system pharmacists, and pharmacy technicians

Type of activity: Application for pharmacists; knowledge for pharmacy technicians
Release date: May 24, 2022
Expiration date: July 24, 2022

Time to complete activity: 1.5 hours
Fee: Free

Educational Objectives

Pharmacist Educational Objectives
At the completion of this activity, participants will be able to:

• Illustrate how integrated continuous glucose monitoring (iCGM) technology has evolved and improved the management of diabetes across patient populations
• Analyze outcomes associated with implementation of iCGM systems
• Dissect potential solutions to improve the implementation of iCGM

Pharmacy Technician Educational Objectives
At the completion of this activity, participants will be able to:

• Recall how integrated continuous glucose monitoring (iCGM) technology has evolved and improved the management of diabetes across patient populations
• Discuss key features and reporting capabilities of iCGM
• Recognize patients with diabetes who would be appropriate candidates for iCGM and refer them to the pharmacist

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity numbers 0290-0000-22-142-L01-P and 0290-0000-22-143-L01-T. The activity is available for CE credit through July 24, 2022.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the broadcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose:
Consultant (advisory board): Novo Nordisk, Bayer, Sanofi
Speakers Bureau: Novo Nordisk

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Dexcom
Consultant: Klinio, Undermyfork, Tempramed
Speakers Bureau: Abbott, Dexcom, Medtronic, Insulet, Bayer, Novo Nordisk

Viral N. Shah, MD, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Sanofi, Novo Nordisk, Eli Lilly, Insulet, Dexcom, Tandem, JDRF, NIH
Consultant: Dexcom, Insulet
Other (advisory board): Medscape, LifeScan, Sanofi

Cara Liday, PharmD, CDCES, has no relevant financial relationships with commercial interests to disclose.

Medical Writing and Editorial Support

Christina H. Sherrill, PharmD, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms